Milla

Milla Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of generic prescription drugs for the U.S. market. As a subsidiary of the Belgium-based Alter Pharma Group, the company specializes in complex generic injectables and niche pharmaceutical products. Milla has successfully secured multiple FDA approvals for essential hospital products, including Sodium Acetate Injection and Magnesium Sulfate Injection. The company strategically targets products that are frequently in shortage or have limited competition to ensure patient access to critical treatments. By leveraging the extensive research, development, and manufacturing capabilities of its parent organization, Milla provides high-quality, cost-effective alternatives to brand-name medications. Its operational model is designed for efficiency, focusing on Abbreviated New Drug Application (ANDA) filings to expand its commercial portfolio.